SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, BTTR, CBZ, MNTX on Behalf of Shareholders |
Globe Newswire |
09/20 |
09:54 |
INDV Alert: Monsey Law Firm of Wohl & Fruchter LLP Reminds Indivior Investors of Important Deadline in Class Action Lawsuit |
Globe Newswire |
09/20 |
09:52 |
U.S. Global Investors Announces an Update to Its $5 Million Stock Buyback Program, Reaffirming Commitment to Shareholder Value and Continuing Monthly Dividend |
Globe Newswire |
09/20 |
09:37 |
IBN Again Selected Official Media Partner for Octane’s Medical Innovation Forum 2024 |
Globe Newswire |
09/20 |
09:35 |
Mullen Provides Update on Volt Mobility $210 Million UAE Order |
Globe Newswire |
09/20 |
09:25 |
Kuehn Law Encourages BTTR, GVP, CBZ, and MNTX Investors to Contact Law Firm |
Globe Newswire |
09/20 |
09:23 |
US will let more people take methadone at home |
AP Online |
09/20 |
09:17 |
Luxury Streetwear Brand Ryoko Rain® is an Official Collaboration Partner for Athlos NYC Track Event |
Globe Newswire |
09/20 |
09:15 |
Range Impact Announces Application to Uplist to the OTCQB Venture Market |
Globe Newswire |
09/20 |
09:15 |
Image Protect, Inc. (OTC:IMTL) Offers Open Letter to Shareholders From New Incoming CEO |
Globe Newswire |
09/20 |
09:15 |
Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman |
Globe Newswire |
09/20 |
09:13 |
Jewish Family Service of MetroWest New Jersey (JFS) Chooses Qualifacts as its Premier EHR & Data Solutions Partner |
Globe Newswire |
09/20 |
09:03 |
Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024 |
Globe Newswire |
09/20 |
09:01 |
Fortinet Honored as Winner of the 2024 SC Awards for Best Professional Certification Program |
Globe Newswire |
09/20 |
09:00 |
Northrop Grumman Announces Webcast, Conference Call of Third Quarter 2024 Financial Results |
Globe Newswire |
09/20 |
09:00 |
The RoyaLand Company Ltd. Announces Preliminary Selected Unaudited Results for the Fiscal Year Ended June 30, 2024 |
Globe Newswire |
09/20 |
09:00 |
MESMERIZE brings community pharmacy leaders together to explore industry’s bright future |
Globe Newswire |
09/20 |
09:00 |
Firefly Neuroscience Advances AI-Driven BNA™ Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis |
Globe Newswire |
09/20 |
09:00 |
ESGL Holdings Limited Reports First Half 2024 Financial Results |
Globe Newswire |
09/20 |
09:00 |
New Bartlett Soybean Processing Plant Strengthens Kansas Economy and North American Supply Chains for Food, Feed and Renewable Fuel |
Globe Newswire |
09/20 |
09:00 |
Check Point Software is Recognized as a Leader in Email Security, Showcasing its Innovative AI-based Threat Intelligence Capabilities |
Globe Newswire |
09/20 |
09:00 |
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs |
Globe Newswire |
09/20 |
09:00 |
MCQ Markets Announces $750,000 Reg CF Offering Making Luxury Asset Investments Accessible to All |
Globe Newswire |
09/20 |
09:00 |
Apollo’s ATLAS SP and BNP Paribas Announce $5 Billion Strategic Collaboration |
Globe Newswire |
09/20 |
09:00 |
Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade |
Globe Newswire |
09/20 |
08:57 |